Author

W. Furuyama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:bulk RNA-seq· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

A. Marzi· 3 shared A. J. Griffin· 2 shared C. S. Clancy· 2 shared K. L. O'Donnell· 2 shared K. Shifflett· 2 shared T. Gourdine· 2 shared T. Thomas· 2 shared A. Jankeel· 1 shared

Activity by Year

2021-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

A. Marzi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Optimization of single dose VSV-based COVID-19 vaccination in hamsters

K. L. O'Donnell, C. S. Clancy, A. J. Griffin, K. Shifflett, T. Gourdine, T. Thomas, C. M. Long, W. Furuyama, A. Marzi

This study evaluates two VSV-based COVID-19 vaccines in hamsters, showing intranasal vaccination provides rapid protection against multiple SARS-CoV-2 variants.

bioRxiv · Sep 3, 2021Microbiology

Ebola virus glycoprotein domains associated with protective efficacy

B. Bhatia, W. Furuyama, T. Hoenen, H. Feldmann, A. Marzi

The paper identifies regions of the Ebola virus glycoprotein that are essential for vaccine vector replication but not for protective immunity.

bioRxiv · May 22, 2021Microbiology

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine

W. Furuyama, K. Shifflett, A. N. Pinksi, A. J. Griffin, F. Feldmann, A. Okumura, T. Gourdine, A. Jankeel, J. Lovaglio, P. W. Hanley, T. Thomas, C. S. Clancy, I. Messaoudi, K. L. O'Donnell, A. Marzi

A single-dose VSV-based vaccine protected nonhuman primates from COVID-19 within 10 days when administered intramuscularly but not intranasally.

bioRxiv · Jan 19, 2021 · PreprintMicrobiology